Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
de Sèze J, Kremer L, Collongues N. de Sèze J, et al. Among authors: kremer l. Rev Neurol (Paris). 2016 Apr-May;172(4-5):256-62. doi: 10.1016/j.neurol.2016.03.003. Epub 2016 May 4. Rev Neurol (Paris). 2016. PMID: 27157418 Review.
Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional study.
Cobo-Calvo Á, d'Indy H, Ruiz A, Collongues N, Kremer L, Durand-Dubief F, Rollot F, Casey R, Vukusic S, De Seze J, Marignier R. Cobo-Calvo Á, et al. Among authors: kremer l. Neurol Neuroimmunol Neuroinflamm. 2019 Dec 13;7(2):e649. doi: 10.1212/NXI.0000000000000649. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31836640 Free PMC article.
Guillain-Barré syndrome related to SARS-CoV-2 infection.
Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, Godon A, Voulleminot P, Kremer L, Chanson JB, de Seze J. Bigaut K, et al. Among authors: kremer l. Neurol Neuroimmunol Neuroinflamm. 2020 May 27;7(5):e785. doi: 10.1212/NXI.0000000000000785. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32461235 Free PMC article. No abstract available.
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
Metzger-Peter K, Kremer LD, Edan G, Loureiro De Sousa P, Lamy J, Bagnard D, Mensah-Nyagan AG, Tricard T, Mathey G, Debouverie M, Berger E, Kerbrat A, Meyer N, De Seze J, Collongues N. Metzger-Peter K, et al. Trials. 2020 Jun 29;21(1):591. doi: 10.1186/s13063-020-04517-6. Trials. 2020. PMID: 32600454 Free PMC article.
906 results